News

The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, and ChemRar Group produced the first 100,000 courses of the Russian coronavirus drug Avifavir in June,…
Read More...

Global investment firm KKR announced that it has entered into a definitive agreement to purchase a controlling stake in J.B. Chemicals & Pharmaceuticals Ltd. (“J.B. Chemicals” or…
Read More...

Johnson & Johnson announced that the European Commission (EC) has granted Marketing Authorisation for its Janssen Pharmaceutical Companies’ Ebola vaccine regimen for the prevention…
Read More...

Bilthoven, The Netherlands based Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and…
Read More...

Pfizer Inc. and BioNTech SE  announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine program, Project…
Read More...

BioInvent International AB announces that it has further extended the research term under its cancer immunotherapy research collaboration and license agreement with Pfizer Inc. until…
Read More...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the first patient with triple negative breast cancer (TNBC) has been dosed in the ongoing phase 1 study…
Read More...

Aligos Therapeutics, Inc. (Aligos), a private biotechnology company focused on the development of targeted antiviral therapies directed against chronic hepatitis B (CHB), COVID-19 and…
Read More...

Prestige BioPharma Ltd. announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its first-in-class anti-PAUF monoclonal antibody, PBP1510,…
Read More...

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has approved Phesgo, a fixed-dose combination of Perjeta (pertuzumab) and Herceptin (trastuzumab) with hyaluronidase,…
Read More...

Meissa Vaccines announced that the company has initiated preclinical studies and manufacturing and completed a pre-IND meeting with the U.S. Food and Drug Administration (FDA) for the…
Read More...

Carmine Therapeutics announced that it has signed a research collaboration agreement with Takeda Pharmaceutical Company Limited to discover, develop and commercialize transformative…
Read More...

Sinclair Research announced completion of successful validation of GLP ototoxicity testing services in partnership with Turner Scientific, an industry leader specializing in nonclinical…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for…
Read More...

VITRAC Therapeutics, LLC (VITRAC) initiated the global clinical development of VIC-1911, an oncology candidate formally known as TAS-119, which was licensed from Taiho Pharmaceutical…
Read More...

Biocare Medical announces a collaborative partnership with Bethyl Laboratories to develop targeted antibodies for cancer research and oncology diagnostics. Bethyl Laboratories has 45…
Read More...

SFA Therapeutics, Inc. announced that the US FDA has provided approval to conduct a clinical trial (officially referred to as an IND) for the treatment of "the appearance of the…
Read More...

Nordic Nanovector ASA announces that the US Food and Drug Administration (FDA) has granted Fast Track designation for investigating Betalutin (177Lu lilotomab satetraxetan) for the…
Read More...

GlaxoSmithKline plc announced the approval of a Japanese New Drug Application (JNDA) by the Ministry of Health, Labour and Welfare for Duvroq (daprodustat) tablets, an oral…
Read More...